NI
RGLS

Numeric Investors’s Regulus Therapeutics RGLS Stock Holding History

Numeric Investors’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,732
Closed -$1.08M – 1152
2016
Q3 		$1.08M Sell
2,732
-4,448
-62% -$1.83M 0.01% 598
2016
Q2 		$2.49M Buy
7,180
+6,963
+3,209% +$4.99M 0.02% 409
2016
Q1 		$180K Buy
+217
New +$173K ﹤0.01% 931
2015
Q3 		– Sell
-460
Closed -$605K – 1131
2015
Q2 		$605K Buy
460
+371
+417% +$599K 0.01% 634
2015
Q1 		$181K Sell
89
-304
-77% -$661K ﹤0.01% 828
2014
Q4 		$757K Buy
+393
New +$699K 0.01% 505
2013
Q4 		– Sell
-1,295
Closed -$1.47M – 855
2013
Q3 		$1.47M Buy
+1,295
New +$1.53M 0.03% 375

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Numeric Investors's RGLS Position: Q4 2016 in Review

Numeric Investors sold out of Regulus Therapeutics (RGLS) in Q4 2016, closing a stake of 2,732 shares — an estimated $1.08M sold.

Numeric Investors first reported a position in RGLS in Q3 2013 and held it in 7 quarters. The position peaked at $2.49M in Q2 2016. 68 funds tracked by Wall St. Rank hold RGLS as of Q4 2016.

  • Numeric Investors reported no remaining Regulus Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Numeric Investors sold 2,732 Regulus Therapeutics shares in Q4 2016, an estimated $1.08M.
  • Numeric Investors first reported a position in Regulus Therapeutics in Q3 2013 and held it in 7 quarters.
  • Numeric Investors's Regulus Therapeutics position peaked at $2.49M in Q2 2016.
  • 68 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2016.

Based on Numeric Investors's 13F filing for Q4 2016, filed 13 Feb 2017.